Brii Biosciences

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. AbbVie To Pay $48m Up Front For Preclin

Brii Biosciences is expanding the scope of its license for an investigational hepatitis B virus (HBV) immunotherapy drug and taking on an HBV vaccine in its more than four-year-old partnership with

With severe acute respiratory syndrome (SARS) in 2003 and then COVID-19, China has seen two pandemics originate and spread fast in the country, which has also become known for its large scientific tal

Six Chinese biotechs are reshuffling their research and development programs to conserve funds amid the persistent downturn in the sector, the companies disclosed in their annual results for 2022. Whi